| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Hemoglobin A1C, Whole Blood
Test CodeHGBA1C - NCMC
CPT Codes
83036
Preferred Specimen
4.0 mL whole blood from Purple EDTA
Minimum Volume
1.0 mL
Transport Temperature
Refrigerate
Specimen Stability
| Temperature | Time |
| Ambient | 24 hours |
| Refrigerate | 5 days |
Methodology
Turbidimetric Inhibition Immunoassay (TINIA)
Setup Schedule
Daily
Report Available
Same day
Reference Range
≤ 5.6%
The American Diabetes Association (ADA) guidelines for interpreting Hemoglobin A1c are as follows:
Non-Diabetic patient: ≤ 5.6%
Increased risk for future Diabetes: 5.7-6.4%
ADA diagnostic criteria for Diabetes: ≥ 6.5%
Values for patients with Diabetes:
Meets ADA's recommended goal for therapy: <7.0%
Exceeds ADA's recommended goal: 7.0-8.0%
ADA recommends reevaluation of therapy: >8.0%
The American Diabetes Association (ADA) guidelines for interpreting Hemoglobin A1c are as follows:
Non-Diabetic patient: ≤ 5.6%
Increased risk for future Diabetes: 5.7-6.4%
ADA diagnostic criteria for Diabetes: ≥ 6.5%
Values for patients with Diabetes:
Meets ADA's recommended goal for therapy: <7.0%
Exceeds ADA's recommended goal: 7.0-8.0%
ADA recommends reevaluation of therapy: >8.0%
Clinical Significance
Useful for identifying patients at increased risk of developing diabetes, diagnosing diabetes, and evaluating long-term blood glucose control in patients with diabetes.
Performing Laboratory
North Colorado Medical Center Laboratory
